Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France.

Lefèvre, Benjamin; Tondeur, Laura; Madec, Yoann; Grant, Rebecca; Lina, Bruno; van der Werf, Sylvie; Rabaud, Christian; Fontanet, Arnaud

Lefèvre, Benjamin; Tondeur, Laura; Madec, Yoann; Grant, Rebecca; Lina, Bruno; van der Werf, Sylvie; Rabaud, Christian; Fontanet, Arnaud.

Lefèvre B; Infectious and Tropical Diseases, CHRU-Nancy, Université de Lorraine, Nancy, France.
Tondeur L; APEMAC, Université de Lorraine, Nancy, France.
Madec Y; Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris 75015, France.
Grant R; Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris 75015, France.
Lina B; Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris 75015, France.
van der Werf S; Sorbonne University, Paris, France.
Rabaud C; CNR des Virus des Infections Respiratoires, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
Fontanet A; VirPath, Centre International de Recherche En Infectiologie, Université de Lyon, Inserm U1111, CNRS UMR5308, École Normale Supérieure de Lyon, Université Claude Bernard Lyon, Lyon, France.

Lancet Healthy Longev ; 2(11): e685-e687, 2021 11.

Article in English | MEDLINE | ID: covidwho-1550177

Subject(s)

COVID-19; SARS-CoV-2; BNT162 Vaccine; Humans; Long-Term Care; Vaccine Efficacy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Healthy Longev Year: 2021 Document Type: Article Affiliation country: S2666-7568(21)00230-0

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google